
Profitability, historical returns, and peer comparisons.
According to HTG Molecular Diagnostics, Inc.’s latest financial reports and current stock price. The company's current ROE is -273.49%. This represents a change of -32.96% compared to the average of -407.94% of the last 4 quarters.
The mean historical ROE of HTG Molecular Diagnostics, Inc. over the last ten years is 20.11%. The current -273.49% ROE has changed -1459.74% with respect to the historical average. Over the past ten years (40 quarters), HTGM's ROE was at its highest in in the June 2017 quarter at 377.34%. The ROE was at its lowest in in the March 2023 quarter at -1065.28%.
Average
20.11%
Median
-79.26%
Minimum
-400.51%
Maximum
619.70%
Discovering the peaks and valleys of HTG Molecular Diagnostics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 142.94%
Maximum Annual ROE = 619.70%
Minimum Annual Increase = -467.58%
Minimum Annual ROE = -400.51%
| Year | ROE | Change |
|---|---|---|
| 2022 | -400.51% | 142.94% |
| 2021 | -164.86% | 14.42% |
| 2020 | -144.08% | 78.97% |
| 2019 | -80.51% | 3.20% |
| 2018 | -78.01% | -112.59% |
| 2017 | 619.70% | 33.10% |
| 2016 | 465.59% | -467.58% |
| 2015 | -126.66% | -318.15% |
| 2014 | 58.06% | 10.75% |
| 2013 | 52.43% | -25.06% |
The current ROE of HTG Molecular Diagnostics, Inc. (HTGM) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-236.49%
5-year avg
-173.60%
10-year avg
20.11%
HTG Molecular Diagnostics, Inc.’s ROE is less than 9 Meters Biopharma, Inc. (0%), greater than Impel Pharmaceuticals Inc. (-3099.99%), less than Accelerate Diagnostics, Inc. (131.82%), greater than InVivo Therapeutics Holdings Corporation (-60.12%), less than Lucy Scientific Discovery Inc. (18.15%), greater than Altamira Therapeutics Ltd. (-111.64%), greater than Neptune Wellness Solutions Inc. (-88.52%), greater than CohBar, Inc. (-58.44%), greater than Timber Pharmaceuticals, Inc. (-209.49%), less than Acorda Therapeutics, Inc. (786.07%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $1.45K | |
| -3099.99% | $956.00K | |
| 131.82% | $859.92K | |
| -60.12% | $995.92K | |
| 18.15% | $906.91K | |
| -111.64% | $1.13M | |
| -88.52% | $453.00 | |
| -58.44% | $1.19M | |
| -209.49% | $1.18M | |
| 786.07% | $821.03K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like HTG Molecular Diagnostics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like HTG Molecular Diagnostics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is HTG Molecular Diagnostics, Inc.'s ROE?
How is the ROE calculated for HTG Molecular Diagnostics, Inc. (HTGM)?
What is the highest ROE for HTG Molecular Diagnostics, Inc. (HTGM)?
What is the 3-year average ROE for HTG Molecular Diagnostics, Inc. (HTGM)?
What is the 5-year average ROE for HTG Molecular Diagnostics, Inc. (HTGM)?
How does the current ROE for HTG Molecular Diagnostics, Inc. (HTGM) compare to its historical average?